According to LabCorp's latest financial reports the company's total assets are $20.20 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $20.15 B | -1.13% |
2021-12-31 | $20.38 B | 1.56% |
2020-12-31 | $20.07 B | 11.22% |
2019-12-31 | $18.04 B | 11.5% |
2018-12-31 | $16.18 B | -2.31% |
2017-12-31 | $16.56 B | 16.29% |
2016-12-31 | $14.24 B | 0.18% |
2015-12-31 | $14.22 B | 94.77% |
2014-12-31 | $7.30 B | 4.82% |
2013-12-31 | $6.96 B | 2.52% |
2012-12-31 | $6.79 B | 10.73% |
2011-12-31 | $6.13 B | -0.83% |
2010-12-31 | $6.18 B | 27.91% |
2009-12-31 | $4.83 B | 3.6% |
2008-12-31 | $4.66 B | 6.9% |
2007-12-31 | $4.36 B | 9.18% |
2006-12-31 | $4.00 B | 3.23% |
2005-12-31 | $3.87 B | 7.63% |
2004-12-31 | $3.60 B | 5.45% |
2003-12-31 | $3.41 B | 30.75% |
2002-12-31 | $2.61 B | 35.35% |
2001-12-31 | $1.92 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
![]() IDEXX Laboratories IDXX | $2.80 B | -86.10% | ๐บ๐ธ USA |
![]() Quest Diagnostics
DGX | $12.79 B | -36.66% | ๐บ๐ธ USA |
![]() Translate Bio
TBIO.defunct | N/A | N/A | ๐บ๐ธ USA |
![]() NeoGenomics
NEO | $1.74 B | -91.39% | ๐บ๐ธ USA |
![]() Qiagen QGEN | $6.28 B | -68.87% | ๐ณ๐ฑ Netherlands |
![]() Enzo Biochem ENZ | $76.45 M | -99.62% | ๐บ๐ธ USA |